Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 63, Number 6, September 28, 2004
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipton, R. B.
Right arrow Articles by Davidai, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipton, R. B.
Right arrow Articles by Davidai, G.
Related Collections
Right arrow All Headache
Right arrow All Clinical trials
Right arrow Clinical trials Randomized controlled (CONSORT agreement)
Right arrowRelated Article
NEUROLOGY 2004;63:1099-1101
© 2004 American Academy of Neurology
Brief Communications

Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination

R. B. Lipton, MD, M. E. Bigal, MD PhD, K. B. Kolodner, ScD, P. B. Gorelick, MD MPH, FACP, K. Wilks, MD, M. Schoebelock, MD and G. Davidai, MD

From the Departments of Neurology (Drs. Lipton and Bigal), Epidemiology and Population Health (Dr. Lipton), Albert Einstein College of Medicine, Bronx, NY; The New England Center for Headache (Dr. Bigal), Stamford, CT; AdvancePCS (Drs. Kolodner and Wilks), Hunt Valley, MD; Department of Neurology (Dr. Gorelick), RUSH Medical College, Chicago, IL; and Boehringer Ingelheim (Drs. Schoebelock and Davidai), Ridgefield, CT.

Address correspondence and reprint requests to Dr. Richard B. Lipton, Albert Einstein College of Medicine, Department of Neurology, 1300 Morris Park Avenue, Bronx, NY 10461; e-mail: Rlipton{at}aecom.yu.edu

The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.

Received December 4, 2003. Accepted in final form May 14, 2004.

Dr. Gorelick has received honoraria in excess of $10,000 from Boehringer Ingelheim.


Related Article

September 28 Highlights
Neurology 2004 63: 946-947. [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.